- Tytuł:
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology April 2017 18(4):500-514
- Czasopismo naukowe